Yukihisa Hatakeyama

TL;DR: It is demonstrated that changes in metabolite pattern are useful for assessing the clinical characteristics of lung cancer and will hopefully lead to the establishment of novel diagnostic tools.

TL;DR: In vivo, AMR/PEM treatment showed synergistic antitumor activity both in A549-bearing and H520-bearing mice and in real-time RT-qPCR analysis and western blotting, expression of the target enzymes of PEM were suppressed in cells treated with amrubicinol alone.

TL;DR: There was a possibility that VBN-guided EBUS-transbronchial diagnosis without fluoroscopy might be equivalent to that under fluoroscope.

TL;DR: A 60-year-old Japanese man who was histologically diagnosed with lung adenocarcinoma harboring L858R mutation of epidermal growth factor receptor is described, which resulted in dramatic improvement in his symptoms and performance status from four to one and he survived for as long as 13.6 months after the initiation of erlotinib therapy.

TL;DR: A fatal clinical course suggested that hemoptysis due to endobronchial aspergilloma in the native lung should have been considered native lung pneumonectomy as a further intervention.